Genenta Science S.p.A. is left out of our screens and market counts tonight, which cover US stocks priced at $5 or more and trading at least $1 million a day on average. Its read below still updates after every close.

SAEN· Industrials› Conglomerates

Genenta Science S.p.A.

Stage 4 · Declining · week 6

As of Nov 4, 2026, Genenta Science S.p.A. is in Stage 4, the downtrend phase, now in week 6 (since Sep 29, 2026). It closed at $0.70, 71.5% below its 52-week high and below its 200-day average, which is falling. In Industrials, 21.5% of stocks are in Stage 2.

Every stock that changed stage on Sep 29, 2026 →

$0.70

Close, Nov 4, 2026

-28.93% on the day

$47.5M · Micro cap

Market Neutral — FadingIndustrials 21.5% in Stage 2-6.1 pts / 20dConglomerates 11.8%-11.8 pts

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Is SAEN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $29 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-29 → 2026-11-04

S4 46w

S2 17w

S4 49w

2023-08-292026-11-04

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 46w → S1 7w → S2 17w → S3 8w → S4 10w → S1 7w → S4 49w → S1 7w → S2 5w → S3 5w → S4 5w current

Total tracked: 166 weeks across 11 stage runs.

SAEN among Conglomerates

All 17 →

Stocks in Conglomerates ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CODID/B/A Compass Diversified Holdings	Stage 3 · wk 2	95	+11.7%
2	RCMTRCM Technologies, Inc.	Stage 2 · wk 13	86	−15.5%
3	DLXDeluxe Corporation	Stage 4 · wk 6	78	+3.9%
4	AIRTAir T, Inc.	Stage 3 · wk 2	74	−6.8%
5	MMM3M Company	Stage 3 · wk 3	69	+18.5%
6	GHCGraham Holdings Company	Stage 3 · wk 7	67	+7.4%
7	HONHoneywell International Inc.	Stage 4 · wk 9	61	+7.3%
8	OTTROtter Tail Corporation	Stage 3 · wk 5	59	−6.0%

vs 52W High

-71.5%

$0.58 lo$2.46 hi

71.5% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 6

1w13w26w

Week 6, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-32.1%

200 DMA: $1.03 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

2.08x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-10.4%

-46.6%

+1.4%

YTD

-50.4%

-72.7%

Sector

Industrials

↓ Peaking

Stage 2%

21.5%

20d Δ

-6.1pp

1M return

-3.1%

3M return

-1.3%

Sector Stage-2 % · last 20 days

Sector has 95 Stage 2 leaders. See Industrials Stage 2 →

Industry

Conglomerates

↓ Peaking

Stage 2%

11.8%

20d Δ

-11.8pp

1M return

+11.1%

3M return

+0.8%

Industry Stage-2 % · last 20 days

Industry has 2 Stage 2 leaders. See Conglomerates Stage 2 →

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-11-04S4

Wk 6 · Vol 2.08x

2026-11-03S4

Wk 6 · Vol 2.88x

2026-11-02S4

Wk 5 · Vol 28.07x

2026-10-30S4

Wk 5 · Vol 1.22x

2026-10-29S4

Wk 5 · Vol 2.91x

2026-10-28S4

Wk 5 · Vol 0.80x

2026-10-27S4

Wk 5 · Vol 0.35x

2026-10-26S4

Wk 4 · Vol 0.52x

2026-10-23S4

Wk 4 · Vol 0.25x

2026-10-22S4

Wk 4 · Vol 0.69x

2026-10-21S4

Wk 4 · Vol 0.59x

2026-10-20S4

Wk 4 · Vol 0.45x

Moving averages & range

50 DMA

$0.77

200 DMA

$1.03

52W High

$2.46

52W Low

$0.58

5D Low

$0.62

Resistance levels (recent highs)

20d High

$0.99

60d High

$1.30

120d High

$2.20

250d High

$2.30

Next resistance

+40.7%

to 20d High

ROE

-38.0%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.6

Against its industry

Conglomerates · 28 companies we cover

Return on equity-38.0%
Higher return on equity than 12%
Profit margin0.0%
Wider margin than 44%
Debt to equity0.35x
Less debt than 76%
Dividend yield0.00%
Higher yield than 0%

Genenta Science S.p.A.: quick answers

What stage is Genenta Science S.p.A. in?

As of Nov 4, 2026, Genenta Science S.p.A. (SAEN) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 29, 2026 and is in week 6. What the four stages mean

Is Genenta Science S.p.A. in an uptrend?

No. Genenta Science S.p.A. is in a Stage 4 downtrend. It trades 32.1% below its 200-day average, which is falling.

How far is Genenta Science S.p.A. from its 52-week high?

Genenta Science S.p.A. closed at $0.70 on Nov 4, 2026, 71.5% below its 52-week high of $2.46. Its 52-week low is $0.58.

How has Genenta Science S.p.A. performed over the past year?

As of Nov 4, 2026, Genenta Science S.p.A. is down 72.7% over the past year and down 50.4% so far in 2026.

Which sector and industry is Genenta Science S.p.A. in?

Genenta Science S.p.A. is in the Conglomerates industry, part of the Industrials sector. 95 stocks in Industrials are in Stage 2, 21.5% of the sector. See the Stage 2 stocks in Industrials

About this companyIndustrials· Conglomerates

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-04. Past data patterns are not indicative of future results. This page is a data analytics tool only.

Markets

Sectors

Screener

Learn